Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings    ZBH

ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/19/2020 10/20/2020 10/21/2020 10/22/2020 10/23/2020 Date
142(c) 141.9(c) 141.82(c) 143.05(c) 142.71(c) Last
1 011 986 589 641 510 841 1 047 453 687 574 Volume
-3.36% -0.07% -0.06% +0.87% -0.24% Change
More quotes
Financials (USD)
Sales 2020 6 827 M - -
Net income 2020 -408 M - -
Net Debt 2020 6 947 M - -
P/E ratio 2020 -75,4x
Yield 2020 0,69%
Sales 2021 8 103 M - -
Net income 2021 1 144 M - -
Net Debt 2021 5 441 M - -
P/E ratio 2021 26,8x
Yield 2021 0,72%
Capitalization 29 548 M 29 548 M -
EV / Sales 2020 5,35x
EV / Sales 2021 4,32x
Nbr of Employees 19 900
Free-Float 66,5%
More Financials
Company
Zimmer Biomet Holdings specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (59.4%): knees replacement (59.2% of net sales), hips replacement (40.8%) ; - surgical products and traumatology equipment (22.5%); - spinal implants (9.4%); - dental... 
More about the company
Notations Surperformance© of Zimmer Biomet Holdings
Trading Rating : Investor Rating :
More Ratings
All news about ZIMMER BIOMET HOLDINGS
10/21ZIMMER BIOMET : Empowers Joint Surgery Candidates Who Have Delayed Procedures, '..
AQ
10/07ZIMMER BIOMET : Announces Webcast and Conference Call of Third Quarter 2020 Fina..
AQ
10/06ZIMMER BIOMET : Announces Webcast and Conference Call of Third Quarter 2020 Fina..
PR
09/29ZIMMER BIOMET HOLDINGS : Ex-dividend day for
FA
09/21ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Termi..
AQ
09/10ZIMMER BIOMET : Announces Quarterly Dividend for Third Quarter of 2020
PR
09/09ZIMMER BIOMET : to Present at Morgan Stanley Virtual Global Healthcare Conferenc..
AQ
09/08ZIMMER BIOMET : to Present at Morgan Stanley Virtual Global Healthcare Conferenc..
PR
08/25NEUROONE MEDICAL TECHNOLOGIES : Announces Zimmer Biomet Distribution Deal For It..
AQ
08/06NEUROONE MEDICAL TECHNOLOGIES : Announces Distribution Deal With Zimmer Biomet F..
AQ
08/05ZIMMER BIOMET : Management's Discussion and Analysis of Financial Condition and ..
AQ
08/04ZIMMER BIOMET : Swings to 2Q Loss Amid Elective-Surgery Decline
DJ
08/04ZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition (fo..
AQ
08/04ZIMMER : 2Q Earnings Snapshot
AQ
07/30ZIMMER BIOMET HOLDINGS : half-yearly earnings release
More news
News in other languages on ZIMMER BIOMET HOLDINGS
07/30ZIMMER BIOMET HOLDINGS : Veröffentlichung des Halbjahresergebnisses
07/30ZIMMER BIOMET HOLDINGS : publication des résultats semestriels
07/15Medicrea n’échappe pas au destin américain des medtech françaises
06/10MEDARTIS : nouvelle responsable pour la région Emea
06/10Medartis ernennt Mareike Loch zur Vice President EMEA
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS
More recommendations
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 30
Average target price 153,00 $
Last Close Price 142,71 $
Spread / Highest target 22,6%
Spread / Average Target 7,21%
Spread / Lowest Target -30,6%
EPS Revisions
Managers
NameTitle
Bryan C. Hanson President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Kenneth R. Tripp Senior VP-Global Operations & Logistics
Suketu P. Upadhyay Executive VP, Chief Financial & Accounting Officer
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS-4.66%29 548
ABBOTT LABORATORIES24.10%190 845
MEDTRONIC PLC-1.79%149 794
BECTON, DICKINSON AND COMPANY-11.65%69 650
HOYA CORPORATION14.02%42 617
BAXTER INTERNATIONAL INC.-3.03%41 050